What is the price-to-earnings ratio of Genmab A/S?
The price-earnings ratio of Genmab A/S is currently 24.15.
Genmab A/S P/E 2024
Genmab A/S P/E
24.15
Ticker
GMAB.CO
ISIN
DK0010272202
WKN
565131
As of Oct 28, 2024, Genmab A/S's P/E ratio was 24.15, a -41.69% change from the 41.42 P/E ratio recorded in the previous year.
The Genmab A/S P/E history
Genmab A/S Aktienanalyse
What does Genmab A/S do?
Genmab A/S is a Danish biotechnology company specializing in the discovery and development of antibody therapies for cancer and other serious diseases. The company was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering Genmab A/S's P/E Ratio
The Price to Earnings (P/E) Ratio of Genmab A/S is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing Genmab A/S's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of Genmab A/S is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in Genmab A/S’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about Genmab A/S stock
How has the price-earnings ratio of Genmab A/S changed compared to last year?
The price-to-earnings ratio of Genmab A/S has increased by -41.69% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Genmab A/S high compared to other companies?
Yes, the price-to-earnings ratio of Genmab A/S is high compared to other companies.
How does an increase in the price-earnings ratio of Genmab A/S affect the company?
An increase in the price-earnings ratio of Genmab A/S would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Genmab A/S affect the company?
A decrease in the price-earnings ratio of Genmab A/S would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Genmab A/S?
Some factors that influence the price-earnings ratio of Genmab A/S are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Genmab A/S pay?
Over the past 12 months, Genmab A/S paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genmab A/S is expected to pay a dividend of 0 DKK.
What is the dividend yield of Genmab A/S?
The current dividend yield of Genmab A/S is .
When does Genmab A/S pay dividends?
Genmab A/S pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genmab A/S?
Genmab A/S paid dividends every year for the past 0 years.
What is the dividend of Genmab A/S?
For the upcoming 12 months, dividends amounting to 0 DKK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genmab A/S located?
Genmab A/S is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genmab A/S kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genmab A/S from 10/28/2024 amounting to 0 DKK, you needed to have the stock in your portfolio before the ex-date on 10/28/2024.
When did Genmab A/S pay the last dividend?
The last dividend was paid out on 10/28/2024.
What was the dividend of Genmab A/S in the year 2023?
In the year 2023, Genmab A/S distributed 0 DKK as dividends.
In which currency does Genmab A/S pay out the dividend?
The dividends of Genmab A/S are distributed in DKK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Genmab A/S stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Genmab A/S
Our stock analysis for Genmab A/S Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genmab A/S Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
